Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Diabetic Footcare Center, based in New Delhi, India, is a specialized healthcare and clinical research facility dedicated to the management of diabetic foot complications. Led by Dr. Amar Pal Singh Suri, the center serves as the national headquarters for the Indian Podiatry Association (IPA) and is a prominent site for clinical trials involving advanced wound care technologies. It offers a range of services including limb salvage procedures, hyperbaric oxygen therapy (HBOT), and specialized wound management using super-oxidized solutions. The center is also a key provider of medical education, hosting workshops and training programs for healthcare professionals in podiatry and diabetic care. Its research contributions include participation in Phase II clinical trials for innovative treatments of infected diabetic foot wounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetic Footcare Center.